Snibe - Public Comps and Valuation Multiples

Snibe Overview

About Snibe

Shenzhen New Industries Biomedical Engineering Co Ltd is researching, developing, producing, and selling a series of fully automatic chemiluminescence immunoassay instruments and supporting reagents.

Founded

1995

HQ

Employees

2.8K+

Website

snibe.com

Sectors

Medical Devices
Laboratory Services
DeepTech
HealthTech

Financials

LTM Revenue $667M

LTM EBITDA $302M

EV

$6.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Snibe Financials

As of November 2025, Snibe reported last 12-month revenue of $667M and EBITDA of $302M.

In the same period, Snibe generated $466M in LTM gross profit and $247M in net income.

See Snibe valuation multiples based on analyst estimates

Snibe P&L

In the most recent fiscal year, Snibe reported revenue of $641M and EBITDA of $322M.

Snibe expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Snibe valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$667M	XXX	$641M	XXX	XXX	XXX
Gross Profit	$466M	XXX	$462M	XXX	XXX	XXX
Gross Margin	70%	XXX	72%	XXX	XXX	XXX
EBITDA	$302M	XXX	$322M	XXX	XXX	XXX
EBITDA Margin	45%	XXX	50%	XXX	XXX	XXX
EBIT	$278M	XXX	$281M	XXX	XXX	XXX
EBIT Margin	42%	XXX	44%	XXX	XXX	XXX
Net Profit	$247M	XXX	$259M	XXX	XXX	XXX
Net Margin	37%	XXX	40%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Snibe including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $667M. EBITDA for the last twelve months was $302M. In the most recent fiscal year, Snibe achieved $641M in revenue and $322M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$667M	Analyst estimates available to subscribers	$641M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$466M	Analyst estimates available to subscribers	$462M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	69.9% gross margin	Analyst estimates available to subscribers	72.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$302M	Analyst estimates available to subscribers	$322M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	45.3% EBITDA margin	Analyst estimates available to subscribers	50.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$278M	Analyst estimates available to subscribers	$281M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	41.6% EBIT margin	Analyst estimates available to subscribers	43.8% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$247M	Analyst estimates available to subscribers	$259M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	37.0% net profit margin	Analyst estimates available to subscribers	40.3% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Snibe

This financial data table provides comprehensive performance metrics for Snibe, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Snibe generated $667M in revenue over the last twelve months.
The company achieved $302M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $466M.
Net income over the last twelve months reached $247M.

Fiscal Year Performance

In the most recent fiscal year, Snibe reported $641M in total revenue.
Fiscal year EBITDA was $322M.
The company maintained a gross profit margin of 72.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was 50.3%.
Net profit margin reached 40.3% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Snibe. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Snibe Stock Performance

Snibe has current market cap of CNY 46.8B (or $6.6B), and EV of CNY 44.6B (or $6.3B).

Market Cap Evolution

Snibe Stock Data

As of December 5, 2025, Snibe's stock price is CNY 60 (or $8).

See Snibe trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$6.3B	$6.6B	XXX	XXX	XXX	XXX	$0.31

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Snibe Valuation Multiples

Snibe's trades at 9.8x EV/Revenue multiple, and 19.6x EV/EBITDA.

See valuation multiples for Snibe and 15K+ public comps

Snibe Financial Valuation Multiples

As of December 5, 2025, Snibe has market cap of $6.6B and EV of $6.3B.

Equity research analysts estimate Snibe's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Snibe has a P/E ratio of 26.8x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$6.6B	XXX	$6.6B	XXX	XXX	XXX
EV (current)	$6.3B	XXX	$6.3B	XXX	XXX	XXX
EV/Revenue	9.5x	XXX	9.8x	XXX	XXX	XXX
EV/EBITDA	20.9x	XXX	19.6x	XXX	XXX	XXX
EV/EBIT	22.7x	XXX	22.4x	XXX	XXX	XXX
EV/Gross Profit	13.5x	XXX	n/a	XXX	XXX	XXX
P/E	26.8x	XXX	25.6x	XXX	XXX	XXX
EV/FCF	26.5x	XXX	48.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Snibe Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Snibe Margins & Growth Rates

Snibe's last 12 month revenue growth is 15%

Snibe's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Snibe's rule of 40 is 67% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Snibe's rule of X is 83% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Snibe and other 15K+ public comps

Snibe Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	15%	XXX	10%	XXX	XXX	XXX
EBITDA Margin	45%	XXX	50%	XXX	XXX	XXX
EBITDA Growth	16%	XXX	2%	XXX	XXX	XXX
Rule of 40	67%	XXX	65%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	83%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	6%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	10%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	28%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial